• Earlier this month, Cookeville Regional Medical Center and Encompass Health announced plans to build a freestanding, 40-bed inpatient rehabilitation hospital on Cookeville Regional’s campus in Tennessee, expanding services for patients recovering from strokes, neurological conditions, and complex injuries and integrating advanced therapy facilities and technologies.
• The alliance not only deepens Encompass Health’s presence in Tennessee but also converts and scales an existing 20-bed unit into a larger, specialized rehabilitation hub within its national network.
• Now we’ll examine how this new Cookeville rehabilitation hospital plan might influence Encompass Health’s long-term growth-focused investment narrative.

Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

Encompass Health Investment Narrative Recap

To own Encompass Health, you need to believe in sustained demand for inpatient rehab, disciplined capital investment, and careful management of staffing and reimbursement pressures. The Cookeville hospital plan fits the existing de novo and partnership playbook, but by itself is unlikely to change the near term focus on labor costs and returns on new capacity, which remain central risks and catalysts for the story.

The most relevant recent announcement alongside Cookeville is Encompass Health’s March 2026 plan for a new 40 bed hospital in Bear, Delaware, another example of capacity expansion aimed at complex neurological and stroke cases. Together, these projects highlight how management is leaning into hospital openings while still balancing dividends, buybacks, and a sizable capital program that investors will want to watch for execution risk and capital efficiency.

However, investors should also be aware that heavy spending on new hospitals could become a problem if...

Encompass Health's narrative projects $7.4 billion revenue and $769.8 million earnings by 2029. This requires 7.9% yearly revenue growth and a $204.1 million earnings increase from $565.7 million today.

Uncover how Encompass Health's forecasts yield a $142.73 fair value, a 39% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community currently estimate Encompass Health’s fair value between US$99.17 and US$153.91, showing a wide span of views. You can weigh those opinions against the company’s ongoing push to open new rehab hospitals, which may affect future returns if construction costs rise or new capacity is underutilized.

Explore 4 other fair value estimates on Encompass Health - why the stock might be worth as much as 50% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Encompass Health research is our analysis highlighting 5 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Encompass Health research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Encompass Health's overall financial health at a glance.

Looking For Alternative Opportunities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Capitalize on the AI infrastructure supercycle with our selection of the 38 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.